NKG2D, An NK Cell Activating Receptor on CD8+ T Cells, Plays An Essential Role In Killing Myeloma Cells

被引：0
|
作者：
Talebian, Laleh [1 ]
Meehan, Kenneth
Patey, Megan E.
Fisher, Dawn A.
Szczepiorkowski, Zbigniew [2 ]
Ernstoff, Marc
Sentman, Charles [1 ]
机构：
[1] Dartmouth Coll, Lebanon, NH 03756 USA
[2] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [1] The natural killer-activating receptor, NKG2D, on CD3+CD8+T cells plays a critical role in identifying and killing autologous myeloma cells
    Talebian, Laleh
    Fischer, Dawn A.
    Wu, Jillian
    Channon, Jacqueline Y.
    Sentman, Charles L.
    Ernstoff, Marc S.
    Meehan, Kenneth R.
    TRANSFUSION, 2014, 54 (06) : 1515 - 1521
  • [2] TGF-β downregulates the activating receptor NKG2D on NK cells and CD8+ T cells glioma patients
    Crane, Courtney A.
    Han, Seunggu J.
    Barry, Jeffery J.
    Ahn, Brian J.
    Lanier, Lewis L.
    Parsa, Andrew T.
    NEURO-ONCOLOGY, 2010, 12 (01) : 7 - 13
  • [3] Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells
    Cerboni, Cristina
    Ardolino, Michele
    Santoni, Angela
    Zingoni, Alessandra
    BLOOD, 2009, 113 (13) : 2955 - 2964
  • [4] NK cells suppress CD8+ T cell immunity via NKG2D in severe aplastic anemia
    Chen, Tong
    Zhang, Tian
    Liu, Chunyan
    Wang, ChaoMeng
    Ding, Shaoxue
    Shao, ZongHong
    Fu, Rong
    CELLULAR IMMUNOLOGY, 2019, 335 : 6 - 14
  • [5] Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
    Verneris, MR
    Karami, M
    Baker, J
    Jayaswal, A
    Negrin, RS
    BLOOD, 2004, 103 (08) : 3065 - 3072
  • [6] Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
    Kushal Prajapati
    Cynthia Perez
    Lourdes Beatriz Plaza Rojas
    Brianna Burke
    Jose A Guevara-Patino
    Cellular & Molecular Immunology, 2018, 15 : 470 - 479
  • [7] Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
    Prajapati, Kushal
    Perez, Cynthia
    Rojas, Lourdes Beatriz Plaza
    Burke, Brianna
    Guevara-Patino, Jose A.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (05) : 470 - 479
  • [8] Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells
    Maasho, K
    Opoku-Anane, J
    Marusina, AI
    Coligan, JE
    Borrego, F
    JOURNAL OF IMMUNOLOGY, 2005, 174 (08): : 4480 - 4484
  • [9] CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
    Emily C. Lerner
    Karolina I. Woroniecka
    Vincent M. D’Anniballe
    Daniel S. Wilkinson
    Aditya A. Mohan
    Selena J. Lorrey
    Jessica Waibl-Polania
    Lucas P. Wachsmuth
    Alexandra M. Miggelbrink
    Joshua D. Jackson
    Xiuyu Cui
    Jude A. Raj
    William H. Tomaszewski
    Sarah L. Cook
    John H. Sampson
    Anoop P. Patel
    Mustafa Khasraw
    Michael D. Gunn
    Peter E. Fecci
    Nature Cancer, 2023, 4 : 1258 - 1272
  • [10] Tumor cell recognition by the NK cell activating receptor NKG2D
    Bryceson, Yenan T.
    Ljunggren, Hans-Gustaf
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (11) : 2957 - 2961
12345